SCHEMBL4687883

SCHEMBL4687883

COc1cc2c(NC(=S)Nc3ccccc3C)ncnc2cc1OCCN1CCOCC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.65
SRC P12931 6/20 0.64
KDR P35968 9/20 0.61
RET P07949 2/20 0.58
EPHA2 P29317 1/20 0.58
EPHB4 P54760 1/20 0.58
FGFR1 P11362 1/20 0.58
FLT1 P17948 1/20 0.58
FLT4 P35916 1/20 0.58
MAPK14 Q16539 1/20 0.56
AURKA O14965 1/20 0.56
ROCK2 O75116 1/20 0.56
ALDH1A1 P00352 1/20 0.56
LCK P06239 1/20 0.56
FYN P06241 1/20 0.56
MET P08581 1/20 0.56
MAPT P10636 1/20 0.56
PDGFRA P16234 1/20 0.56
LTK P29376 1/20 0.56
TTK P33981 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4688003 0.91 EGFR (0.65) EGFRSRCKDRRETEPHA2
SCHEMBL4693023 0.91 RET (0.61) EGFRSRCKDRRETEPHA2
SCHEMBL4686384 0.87 KDR (0.61) EGFRSRCKDRRETEPHA2
SCHEMBL4690799 0.87 SRC (0.64) EGFRSRCKDRRETAURKA
SCHEMBL4689817 0.87 SRC (0.64) EGFRSRCKDRRETAURKA
SCHEMBL4686900 0.85 KDR (0.65) EGFRSRCKDRRETEPHA2
SCHEMBL4689828 0.83 RET (0.60) EGFRKDRRETEPHA2EPHB4
SCHEMBL4690075 0.81 EGFR (0.64) EGFRSRCKDRRETEPHA2
SCHEMBL6163276 0.77 HDAC1 (0.72) EGFRSRCKDRRETAURKA
SCHEMBL6163286 0.77 HDAC1 (0.72) EGFRSRCKDRRETAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed